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Abstract
Hyperglycemia is associated with generation of reactive oxygen species (ROS), and this action may contribute to
accelerated atherogenesis. We tested the hypothesis that hyperglycemia produces alterations in left anterior
descending coronary artery (LAD) wall shear stress concomitant with endothelial dysfunction and ROS
production in dogs (n = 12) instrumented for measurement of LAD blood flow, velocity, and diameter. Dogs were
randomly assigned to receive vehicle (0.9% saline) or the superoxide dismutase mimetic 4- hydroxy-2,2,6,6tetramethylpiperidine-1-oxyl (tempol) and were administered intravenous infusions of d-glucose to achieve
target blood glucose concentrations of 350 and 600 mg/dl (moderate and severe hyperglycemia, respectively).
Endothelial function and ROS generation were assessed by coronary blood flow responses to acetylcholine (10,
30, and 100 ng/kg) and dihydroethidium fluorescence of myocardial biopsies, respectively. Indexes of wall shear
stress were calculated with conventional fluid dynamics theory. Hyperglycemia produced dose-related
endothelial dysfunction, increases in ROS production, and reductions in oscillatory shear stress that were
normalized by tempol. The results suggest a direct association between hyperglycemia-induced ROS production,
endothelial dysfunction, and decreases in oscillatory shear stress in vivo.
reactive oxygen species (ROS) have been implicated in the pathogenesis of cardiovascular disease during
diabetes mellitus and hyperglycemia. Several potential mechanisms have been identified that may account for
increases in ROS generation during hyperglycemia including glucose autooxidation (2), mitochondrial superoxide
anion overproduction by the electron transport chain (32), depletion of tetrahydrobiopterin (34), and synthesis
of advanced glycation end-products (36). Hyperglycemia inhibits endothelium-dependent coronary vasodilation
through oxidant-sensitive mechanisms (20, 21, 38). A disproportionate increase in superoxide anion compared
with nitric oxide (NO) concentrations occurs during hyperglycemia that may account for endothelial dysfunction
by altering the balance of oxidant stress (2, 5, 6), and this effect is attenuated by free radical scavengers that
indirectly increase the availability of NO (2,29, 35, 38).
Hyperglycemia has also been shown to adversely alter vascular fluid dynamics. An inverse relation between
fasting blood glucose concentrations and wall shear stress has been observed in patients with diabetes
compared with age-matched controls (15, 16), and endothelium-derived relaxing factors including NO are

modulated by wall shear stress in a frequency- and amplitude-dependent manner (11,12). Regions of the arterial
vasculature that are chronically exposed to low-magnitude and oscillatory wall shear stress are known to be
more susceptible to the development of atherogenesis (9,23). Collectively, these studies suggest that
hyperglycemia-induced ROS production may alter endothelial function and account for reductions in indexes of
wall shear stress. To date, no studies have examined the direct effects of hyperglycemia on coronary wall shear
stress, ROS production, and endothelial function simultaneously in vivo. We tested the hypothesis that
hyperglycemia-induced ROS production is linked to coronary endothelial dysfunction and decreases in wall shear
stress in dogs.

MATERIALS AND METHODS
All experimental procedures and protocols used in this investigation were reviewed and approved by the
Institutional Animal Care and Use Committee of the Medical College of Wisconsin. All conformed to the Guiding
Principles in the Care and Use of Animals of the American Physiological Society and the Guide for the Care and
Use of Laboratory Animals of the National Institutes of Health (7th ed., Washington, DC: National Academy
Press, 1996).

Surgical preparation.
Implantation of instruments was described previously (24). Adult mongrel dogs of either sex and weighing
between 18 and 24 kg were fasted overnight and anesthetized with barbital (200 mg/kg) and pentobarbital
sodium (15 mg/kg). After endotracheal intubation, dogs were ventilated using positive pressure with an airoxygen mixture (FiO2 = 0.28–0.30). Arterial blood gas tensions and acid-base status were maintained within
physiological limits by adjusting tidal volume and respiratory rate. Fluid-filled catheters were inserted into the
right femoral vein and artery for fluid administration and arterial blood gas sampling, respectively. A
thoracotomy was performed in the fifth intercostal space, the lungs were gently retracted, and the pericardium
was incised. A dual micromanometer-tipped catheter was inserted into the left ventricle (LV) and ascending
aorta for measurement of LV and arterial pressures, respectively, and the maximum rate of increase of LV
pressure (dP/dtmax). A 1.5- to 2-cm segment proximal to the first diagonal branch of the left anterior descending
coronary artery (LAD) was isolated, and 2.5-mm ultrasonic segment length (Triton, San Diego, CA) and transit
time blood flow (Transonic Systems, Ithaca, New York) transducers were placed around the vessel for
measurement of external diameter and regional blood flow (Fig.1A). A precalibrated 20-MHz pulsed Doppler
flow probe was placed around the LAD just distal to the first diagonal branch to measure local blood flow
velocity at the myocardial and pericardial luminal surfaces (Fig. 1B). A fluid-filled catheter was inserted into the
left atrium through the atrial appendage for administration of acetylcholine. Fluid deficits were replaced before
experimentation with 500 ml of 0.9% saline, which was continued at 3 ml · kg−1 · h−1for the duration of each
experiment. Hemodynamic data were continuously monitored on a polygraph and simultaneously digitized (364
Hz) with a computer interfaced with an analog-to-digital converter.

Fig. 1.A: schematic diagram of the instrumentation used to measure left anterior descending coronary artery
(LAD) blood flow velocity and LAD external diameter. B: location of the myocardial and pericardial luminal
surfaces.

Experimental protocol.
Baseline systemic and coronary hemodynamics were recorded 90 min after instrumentation was completed.
Dogs were randomly assigned to receive 0.9% saline (vehicle; n = 6) or the superoxide dismutase mimetic 4hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (tempol; 100 mg/kg in 0.9% saline over 15 min; Sigma, St. Louis,
MO;n = 6). Hemodynamics were acquired under steady-state conditions after vehicle or tempol pretreatment
and during acetylcholine infusions (10, 30, and 100 ng/kg) (27). Tissue samples were removed with a biopsy
needle (Bard, Billerica, MA) during each intervention from the left circumflex coronary artery perfusion territory
for measurement of ROS. Blood glucose concentrations and arterial blood gas tensions were determined during
each intervention. After the administration of vehicle or tempol and acetylcholine, blood glucose concentrations
were sequentially increased to 350 and 600 mg/dl (moderate and severe hyperglycemia, respectively) with an
intravenous infusion of d-glucose. Target concentrations of blood glucose were selected on the basis of a
previous investigation demonstrating the ability of hyperglycemia to cause dose-dependent reductions in
coronary collateral blood flow in dogs (19). Each target blood glucose concentration was maintained for 90 min,
and systemic and coronary hemodynamics before and during administration of acetylcholine were recorded.
Myocardial biopsies were also obtained during each intervention in the presence or absence of hyperglycemia.

Detection of ROS.
Production of ROS was quantified during each intervention from myocardial biopsy samples with the fluorescent
dye dihydroethidium. Dihydroethidium is oxidized by intracellular ROS to produce fluorescent ethidium that is
subsequently intercalated in DNA, further amplifying its fluorescence (4). In cell-free assays, the addition of
hydrogen peroxide to dihydroethidium does not increase ethidium fluorescence (28). Thus an increase in
dihydroethidium oxidation and the subsequent increase in fluorescence are highly suggestive of superoxide
generation. Myocardial biopsy samples were incubated in PBS at 37°C overnight, washed with PBS, and
incubated in 5 μM dihydroethidium for 30 min. Images were obtained from each intervention with a laser

fluorescence imaging system (Odyssey Laser Scanning Confocal Microscopic Imaging System; Noran Instruments,
Madison, WI) mounted on a microscope (Optiphot; Nikon, Tokyo, Japan) and stored for off-line analysis on a
computer workstation equipped with image-analysis software (MetaMorph; Universal Imaging, Downingtown,
PA). Excitation was produced with a krypton-argon laser at a wavelength of 488 nm and emitted fluorescence
was measured at 610 nm. The pixel intensity of each myocyte nucleus was determined after compensating for
background fluorescence by subtraction of an area without cells or minimal cytosolic fluorescence. For each
experiment, 7 images were obtained at each intervention and the intensity of 10 myocardial nuclei were
analyzed in each image.

Determination of endothelial function.
Endothelial function was quantified by the coronary vasodilator response to acetylcholine (27). Acetylcholine
infusions were administered into the left atrial appendage during each intervention at a rate of 0.5 μl/s for 4 s.
The rate and duration of acetylcholine administration were selected to achieve increases in coronary blood flow
similar to those described previously (27). Hemodynamics were allowed to return to steady-state conditions
before subsequent doses of acetylcholine were administered.

Ensemble averaging of hemodynamics.
LV and aortic blood pressure, LAD blood flow and velocity, and LAD external diameter waveforms were digitally
recorded for each intervention. A representative time series of one cardiac cycle for each waveform was
generated with a custom-designed MATLAB (MathWorks, Natick, MA) program that identified peak LV pressure
to temporally align the variables in each digitized waveform, segment each variable time series, and ensembleaverage the segments.

Determination of internal LAD diameter.
The LAD coronary artery was excised, and the length (L) of the vascular segment was determined in situ at the
completion of each experiment. The internal LAD radius (ri) was determined with the equation ri =
(r2oo2 −V/Lπ)½, wherer2oo2 is the external LAD radius andV is the ratio of the excised vessel weight to density
(assumed as 1.06 g/ml) (31).

Determination of local coronary blood flow velocity.
Local blood flow velocity at the pericardial and myocardial luminal surfaces (Fig. 1B) of the LAD segment was
determined using pulsed Doppler techniques (1, 24, 26). Briefly, a piezoelectric crystal with a stationary
predetermined insonation angle that is fixed within a Doppler probe is deformed, emitting an ultrasonic pulse
that propagates through the vessel wall to a specified depth. The pulse is then reflected back to the crystal and
interpreted as a frequency shift. To ensure repeatability between interventions and experiments, Doppler pulse
penetration depth had been previously correlated to values on a digital voltmeter. Digitized sample volumes
(∼0.23 mm3) were obtained at 12 axial depths across the vessel and converted to blood flow velocity by
determination of insonation angle as previously described (1). Velocity waveforms at each axial depth were
ensemble-averaged and spatially aligned to reconstruct velocity profiles for each intervention. Least-squares
interpolation was then performed to acquire near-wall velocity assuming no slip at the vessel wall.

Determination of blood viscosity.
Blood samples (3 ml each) were withdrawn from the femoral artery catheter during each intervention for
measurement of blood viscosity. Samples were placed in EDTA-containing vials and agitated continuously to
maintain uniform cellular composition. Blood viscosity was measured in duplicate at 37°C for five different shear
rates (375, 187.5, 75, 56.25, and 30 s−1) with a cone and plate viscometer (DVII+; Brookfield Engineering Labs,
Stoughton, MA). Blood viscosity was then plotted against shear rate, and equations describing a three-constant

exponential decay relationship of the curve were obtained for each intervention by using a MarquardtLevenberg algorithm with commercially available software (Sigma Plot 2000; SPSS, Chicago, IL).

Determination of global and local indexes of shear stress.
Shear rate was determined by two methods. Global shear rate (γ) within the LAD vascular segment bounded by
the surgical instrumentation was estimated from Poiseuille's law using the equation γ = 4Q˙πr3ii3, whereQ˙ is the
rate of coronary blood flow. Local wall shear rate was calculated from blood velocity measurements at the LAD
coronary artery walls nearest to the pericardial and myocardial luminal surfaces (Fig. 1B) by a finite difference
method using the differential equation γu = −∂u/∂r, where ∂u/∂r is the partial derivative of the velocity
magnitude with respect to the radial vessel position (r) (13). Global (τ) and local (τu) shear stress for each time
point in the cardiac cycle were calculated as the product of the measured in vivo viscosity and the respective
global or local shear rate. Oscillatory shear stress (τos) was determined as the magnitude of the shear stress
waveform (Fig. 2). The rate of oscillatory shear stress (τ˙os) was also calculated as the product of τos and heart
rate.

Fig. 2.Ensemble-averaged wall shear stress waveform obtained from a typical experiment during baseline
conditions. Oscillatory wall shear stress (τos) was determined as the magnitude of the wall shear stress waveform
as depicted.

Statistical analysis.
Statistical analysis of data within and between groups was performed with multiple ANOVA for repeated
measures, followed by Student-Newman-Keuls test. A P value <0.05 was considered to be statistically significant.
All data are expressed as means ± SE.

RESULTS
Fourteen dogs were instrumented to obtain twelve successful experiments. Two dogs were excluded from the
control group because of technical problems with instrumentation. ROS measurements for one dog in the
tempol group were excluded because of inadequate dihydroethidium staining.
The hemodynamic effects of tempol and hyperglycemia are summarized in Table 1. No differences in baseline
hemodynamics were observed between vehicle- and tempol-pretreated dogs. There was a small but significant
increase in blood glucose concentration before the administration of d-glucose in tempol-treated dogs.
Hyperglycemia significantly (P < 0.05) increased LV dP/dtmax in dogs receiving vehicle, but heart rate, LV and
aortic pressures, coronary blood flow, and LAD diameter were unchanged. In contrast, heart rate and mean
arterial and LV systolic pressures were decreased during hyperglycemia in dogs pretreated with tempol.

Hyperglycemia attenuated increases in coronary blood flow in response to acetylcholine in dogs receiving
vehicle (e.g., 242 ± 30% at baseline compared with 190 ± 27% increase from control during moderate
hyperglycemia; Fig.3). Pretreatment with tempol completely abolished this hyperglycemia-induced attenuation
of coronary vasodilation in response to acetylcholine. Infusions ofd-glucose produced dose-related increases in
fluorescence intensity in dogs receiving vehicle (Fig.4). In contrast, no differences in fluorescence intensity were
observed during hyperglycemia in dogs pretreated with tempol.
Table 1. Systemic and coronary hemodynamics

Baseline
HR, beats/min
Vehicle
Tempol
MBP, mmHg
Vehicle
Tempol
LVSP, mmHg
Vehicle
Tempol
LVEDP, mmHg
Vehicle
Tempol
dP/dtmax, mmHg/s
Vehicle
Tempol
CBF, ml/min
Vehicle
Tempol
LAD diameter, mm
Vehicle
Tempol
Blood glucose
concentration, mg/dl
Vehicle
Tempol

Moderate
Hyperglycemia

Severe
Hyperglycemia

126 ± 7
117 ± 4

120 ± 9
99 ± 5*

129 ± 11
103 ± 3*,†

100 ± 5
92 ± 4

105 ± 5
80 ± 4*,†

107 ± 4
84 ± 2*,†

115 ± 5
103 ± 4

118 ± 5
91 ± 3*,†

122 ± 5
95 ± 2*,†

8±1
8±1

9±1
8±2

8±1
8±2

1,640 ± 100
1,530 ± 130

1,690 ± 110
1,590 ± 130

1,910 ± 170*
1,780 ± 190

40 ± 3
37 ± 4

36 ± 4
38 ± 3

41 ± 6
40 ± 5

2.5 ± 0.2
2.1 ± 0.1

2.6 ± 0.2
2.1 ± 0.1†

2.6 ± 0.2
2.1 ± 0.1

69 ± 4
89 ± 5†

346 ± 22*
355 ± 31*

581 ± 13*
573 ± 6*

Data are means ± SE. Vehicle, 0.9% saline; tempol, 4-hydroxy-2,2,6,6-tetrametylpiperidine 1-oxyl; HR, heart rate;
MBP, mean arterial blood pressure; LVSP and LVEDP, left ventricular (LV) systolic and end-diastolic pressures,
respectively; dP/dtmax, maximal rate of increase of LV pressure; CBF, coronary blood flow; LAD, left anterior
descending coronary artery.
*Significantly (P < 0.05) different from baseline;
†significantly (P < 0.05) different from the respective value in the vehicle group.

Fig. 3.Percent increase in LAD blood flow in response to left atrial administration of 10 (A), 30 (B), and 100 (C)
ng/kg acetylcholine under control conditions and during hyperglycemia in dogs receiving vehicle and tempol. *
Significantly (P < 0.05) different from baseline.

Fig. 4.Representative photomicrographs illustrate the ethidium-DNA fluorescence in nuclei of cardiac myocytes
as an index of production of reactive oxygen species under control conditions and during hyperglycemia in
vehicle- and tempol-pretreated dogs. Histograms depict fluorescence intensity before and during hyperglycemia
in dogs receiving vehicle and tempol. * Significantly (P < 0.05) different from baseline; †significantly (P < 0.05)
different from the respective value in tempol-pretreated dogs; §significantly (P < 0.05) different from moderate
hyperglycemia.
No differences in blood viscosity were observed during administration of d-glucose at each shear rate in dogs
pretreated with vehicle or tempol (Table 2). Pretreatment with tempol decreased blood viscosity compared with
that in dogs receiving vehicle at shear rates ≤75 s−1 under baseline conditions. Blood viscosity was also
consistently lower in dogs receiving tempol compared with vehicle during hyperglycemia.

Table 2. Blood viscosity

Shear Rate
375 s−1
Vehicle
Tempol
187.5 s−1
Vehicle
Tempol
75 s−1
Vehicle
Tempol
56.25 s−1
Vehicle
Tempol
30 s−1
Vehicle
Tempol

Baseline

Moderate Hyperglycemia Severe Hyperglycemia

3.47 ± 0.28
3.01 ± 0.11

3.45 ± 0.15
2.91 ± 0.13†

3.42 ± 0.08
2.88 ± 0.14†

3.86 ± 0.26
3.23 ± 0.11

3.81 ± 0.16
3.16 ± 0.15†

3.87 ± 0.08
3.11 ± 0.16†

4.45 ± 0.28
3.60 ± 0.11†

4.40 ± 0.19
3.37 ± 0.14†

4.32 ± 0.10
3.40 ± 0.17†

4.85 ± 0.35
3.83 ± 0.12†

4.77 ± 0.24
3.65 ± 0.14†

4.60 ± 0.15
3.57 ± 0.19*,†

5.71 ± 0.40
4.36 ± 0.17†

5.53 ± 0.31
4.26 ± 0.21†

5.14 ± 0.15
4.11 ± 0.16†

Data are means ± SE. Vehicle, 0.9% saline.
*Significantly (P < 0.05) different from baseline;
†significantly (P < 0.05) different from the respective value in the vehicle group.

Global and myocardial wall shear stress were similar between vehicle- and tempol-pretreated groups under
baseline conditions and during hyperglycemia (Table 3). Pericardial wall shear stress was significantly reduced in
dogs pretreated with tempol compared with those receiving vehicle during severe hyperglycemia.
Hyperglycemia decreased global and myocardial oscillatory shear stress in dogs receiving vehicle but not tempol
(Fig.5). In contrast, oscillatory wall shear stress at the pericardial wall was unchanged during hyperglycemia.
Hyperglycemia reduced the rate of global oscillatory shear stress in dogs receiving vehicle but not tempol (Fig.6).
Reductions in the rate of shear stress oscillation were also observed at the myocardial luminal surface during
moderate and severe hyperglycemia in dogs pretreated with vehicle and during severe hyperglycemia in dogs
pretreated with tempol. No differences were observed in the rate of oscillatory wall shear stress at the
pericardial luminal surface within and between groups.
Table 3. Global and local wall shear stress

Baseline
Global shear stress
Vehicle
9.4 ± 1.5
Tempol
11.3 ± 2.6
Myocardial wall shear stress
Vehicle
8.2 ± 1.2
Tempol
6.6 ± 1.5
Pericardial wall shear stress
Vehicle
8.3 ± 1.7
Tempol
7.3 ± 0.4

Moderate Hyperglycemia Severe Hyperglycemia
8.2 ± 1.4
8.4 ± 1.5

8.6 ± 1.5
9.7 ± 1.2

6.8 ± 0.6
8.3 ± 1.4

7.4 ± 1.4
6.7 ± 1.1

9.7 ± 1.2
8.3 ± 0.6

11.2 ± 1.0
6.8 ± 0.83-150

Data (in dyn/cm2) are means ± SE. Vehicle, 0.9% saline.
F3-150Significantly (P < 0.05) different from the respective value in the vehicle group.

Fig. 5.Alterations in global (A) and local wall shear stress at the myocardial (B) and pericardial (C) luminal
surfaces at baseline and during hyperglycemia and in the absence (vehicle) or presence of tempol. * Significantly
(P < 0.05) different from baseline; †significantly (P < 0.05) different from the respective value in dogs pretreated
with tempol.

Fig. 6.Alterations in the rate of oscillatory global (A), myocardial (B), and pericardial (C) wall shear stress under
baseline conditions and during hyperglycemia in the absence (vehicle) or presence of tempol. * Significantly (P <
0.05) different from baseline.

DISCUSSION
Endothelial dysfunction and increased production of ROS have been implicated in the pathogenesis of
cardiovascular disease in patients with diabetes mellitus. Previous investigations demonstrated that the
coronary endothelial dysfunction that occurs during hyperglycemia may be partially reversed by scavengers of
oxygen-derived reactive intermediates (2, 21, 27, 30). The current results support these previous findings and
further suggest that production of ROS during hyperglycemia contributes to reductions in oscillatory global and
local wall shear stress in vivo. The results also demonstrate that the free radical scavenger tempol reverses
hyperglycemic-induced decreases in oscillatory wall shear stress, indicating that ROS are responsible for these
abnormalities in coronary fluid dynamics. The findings indicate that oscillatory but not mean wall shear stress
was reduced during acute hyperglycemia. In contrast, decreases in mean wall shear stress were observed
previously in arterial vessels obtained from patients with or experimental models of diabetes (15, 23). Whether
these differences in indexes of wall shear stress observed during acute compared with chronic hyperglycemia
represent a temporal adaptation to prolonged ROS generation remains to be evaluated.
Oscillatory shear stresses measured at the myocardial and pericardial luminal surfaces of the coronary artery
were differentially altered by hyperglycemia in the current investigation (Fig. 5). Previous fluid dynamic studies
in the LAD and left main coronary artery showed that blood flow velocity profiles are skewed toward the
pericardial surface, causing the velocity profile at the myocardial surface to become less steep and resulting in
lower wall shear stress at the myocardial surface compared with the pericardial surface (Fig. 1B; Refs. 9, 23). A

greater degree of flow reversal also occurs at the myocardial compared with the pericardial surface (22). This
effect preferentially establishes lower oscillatory wall shear stress with a greater deviation of the principal wall
shear stress vector from the dominant flow direction at the myocardial wall. These differences in wall shear
stress profiles between myocardial and pericardial surfaces have been postulated to be responsible for the
preferential location of atherosclerotic plaque formation at the myocardial wall in arteries obtained from
patients with coronary or vascular occlusive disease (8, 9, 23). In contrast to low oscillatory shear stress states,
increases in mean shear stress may have antiatherogenic effects by increasing superoxide dismutase (7) and NO
synthase expression (40) and by increasing production of vasodilator prostanoids (33). Localized decreases in
oscillatory wall stress at the myocardial wall observed during acute hyperglycemia in the current investigation
may contribute to accelerated atherosclerosis during chronic hyperglycemia. This contention is supported by
recent findings that endothelial dysfunction and increased vascular oxidative stress predict coronary artery
disease in humans (10, 25). ROS production and subsequent changes in oscillatory shear stress may be a link
between diabetes-induced hyperglycemia and progression of vascular disease. This intriguing hypothesis will
require further investigation to confirm, however.
Hyperglycemia is well known to produce endothelial dysfunction in coronary arteries dependent or independent
of diabetes (20,27). The ability of tempol to restore endothelial function during hyperglycemia observed in the
current investigation supports the results of a previous study in which a superoxide dismutase mimetic
enhanced the vasodilator responsiveness of isolated aortic rings harvested from diabetic rats (30). Thus the
current and previous studies strongly implicate a role for ROS in endothelial dysfunction during acute and
chronic hyperglycemia. The present results further imply that hyperglycemia-induced endothelial dysfunction
may precipitate flow conditions implicated in atherogenesis. Tempol reversed both the endothelial dysfunction
(Fig. 3) and the decreases in oscillatory wall shear stress (Fig. 5) observed during hyperglycemia. These results
suggest that indexes of wall shear stress may be useful as indirect indicators of oxidative stress in regions of
arterial vasculature that may be susceptible to subsequent atherosclerosis.
The results of the current investigation should be interpreted within the constraints of several potential
limitations. Heart rate and mean arterial pressure were lower in dogs treated with tempol than in those
receiving saline during hyperglycemia. These hemodynamic effects have been previously reported with tempol
(39). The decreases in heart rate may account for the reduction in the rate of oscillatory shear stress observed
during the target blood glucose concentration of 600 mg/dl in tempol-pretreated dogs. However, the rates of
global and myocardial surface oscillatory shear stress were lower in dogs receiving vehicle than in those
pretreated with tempol during hyperglycemia (Fig. 6). These data suggest that differences in the frequency of
wall shear stress oscillations exerted on the endothelium between groups were not solely attributed to
differences in heart rate.
Blood viscosity was significantly reduced during the 600 mg/dl blood glucose concentration at a shear rate of 56
s−1 in dogs pretreated with tempol. This reduction in blood viscosity is probably not physiologically relevant
because the minimum shear rate determined from average regional blood flow velocity and internal LAD
diameter for this experimental group was 67 s−1 (data not shown). Nevertheless, equations describing the
relationship of blood viscosity and shear rate below 67 s−1 were required to evaluate the dynamic behavior of
blood viscosity and shear stress for temporally varying shear rates. Blood viscosities at several shear rates were
also significantly lower in the tempol- compared with vehicle-pretreated dogs. However, reductions in global
and myocardial oscillatory wall shear stress during hyperglycemia in dogs pretreated with vehicle were greater
than those observed in tempol-treated dogs. Thus alterations in wall shear stress were probably dependent on
shear rate and not blood viscosity. These results also strongly suggest that the wall shear stress data presented
here may actually underestimate changes produced by hyperglycemia.

Intravenous administration of d-glucose may have caused hyperinsulinemia in the normal dogs used for the
present investigation. However, we previously demonstrated (18) that many of the effects of hyperglycemia on
ischemic myocardium occur independently of plasma insulin concentration. Coronary microvascular responses
to graded coronary artery occlusion are similar in hyperglycemic (hyperinsulinemic) and diabetic (insulinopenic)
dogs (17). l-Arginine restores coronary collateral blood flow during hyperglycemia without altering plasma
insulin concentrations (19). Thus our previous findings suggest that hyperinsulinemia is unlikely to account for
the deleterious effects of hyperglycemia observed in the current or previous investigations. The presence of
hyperinsulinemia may actually underestimate the impact of hyperglycemia on the coronary circulation because
recent evidence indicates that insulin increases myocardial blood flow in normoglycemic patients (14).
The estimation of localized wall shear stress in arterial vessels with pulsed Doppler techniques may be prone to
error for a Reynolds number typical of the blood flow through the coronary arteries (26). These errors in
measurement may be attributed to the method of acquiring near-wall fluid velocity. The most precise technique
assumes a fixed point on the vessel wall and then uses measured velocity points to calculate wall shear stress by
least-squares interpolation. This method was implemented in the current investigation. In addition, the identical
pulsed Doppler probe with a fixed insonation angle was used in each dog to minimize error. Local wall shear
stress values reported previously for the LAD bifurcation (range of 5 to 33 dyn/cm2; Ref. 37) were also very
similar to those obtained for myocardial and pericardial luminal surfaces of the LAD under control conditions in
the current investigation (range of 5 to 29 dyn/cm2).
Measurement of ROS was conducted in the cardiac myocyte and not the endothelium. Recent evidence suggests
that an important source of hyperglycemia-induced ROS is the mitochondrial electron transport chain within the
cardiac myocyte (32). Thus determination of fluorescence intensities in myocardial nuclei identifies a likely
source of ROS production that may subsequently affect coronary endothelial function. However, additional
studies will be required to verify this hypothesis. Production of ROS may actually be underestimated by the
dihydroethidium technique during hyperglycemia because the amount of dihydroethidium oxidized to ethidium
may decrease as the rate of ROS generation increases (3). Such a situation could have occurred during severe
hyperglycemia in the current investigation. Nevertheless, although measurements of ROS production may have
underestimated the amount of ROS generated during hyperglycemia, the dose of tempol used in the present
investigation was probably adequate to scavenge these reactive intermediates because nuclei fluorescence and
endothelial function were unchanged after administration of intravenous hyperglycemia in dogs pretreated with
tempol. As such, fluorescent intensity and endothelial function were unaffected by hyperglycemia for dogs in
the tempol-treated group.
In summary, the present results indicate that acute hyperglycemia increases ROS production in vivo. These
reactive intermediates cause endothelial dysfunction and reduce both global and local oscillatory wall shear
stress in intact coronary arteries. Whether the influence of acute hyperglycemia on ROS-dependent decreases in
wall shear stress and endothelial function is linked to a subsequent increase in cardiovascular risk during
diabetes remains to be established.
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